PSK1 COST EFFECTIVENESS OF THE USE OF INFLIXIMAB COMPARED TO OTHER BIOLOGICAL AGENTS (BA) IN THE SYSTEMIC TREATMENT OF MODERATE TO SEVERE PSORIASIS

May 1, 2007, 00:00
10.1016/S1098-3015(10)68838-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)68838-9/fulltext
Title : PSK1 COST EFFECTIVENESS OF THE USE OF INFLIXIMAB COMPARED TO OTHER BIOLOGICAL AGENTS (BA) IN THE SYSTEMIC TREATMENT OF MODERATE TO SEVERE PSORIASIS
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68838-9&doi=10.1016/S1098-3015(10)68838-9
First page :
Section Title :
Open access? : No
Section Order : 627
Categories :
Tags :
Regions :
ViH Article Tags :